Successful prevention of the transmission of vancomycin-resistant enterococci in a Brazilian public teaching hospital;Sucesso no controle da transmissão hospitalar de Enterococos resistentes a vancomicina em um hospital universitário público brasileiro

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 45, Issue 2, 2012, Pages 184-188

  Rossini, Flávia Alves Ferreira ^a   Fagnani, Renata ^a   Leichsenring, Mirtes Loeschner ^a   Dantas, Sônia Regina Perez Evangelista ^a   Cardoso, Luís Gustavo de Oliveira ^a   Levy, Carlos Emílio ^a   Moretti, Maria Luiza ^a   Trabasso, Plínio ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Disease outbreaks; Enterococcus; Epidemiology; Infection control; Vancomycin resistance

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; METRONIDAZOLE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BRAZIL; CATHETER INFECTION; CHILD; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE COURSE; EDUCATIONAL STATUS; ENGINEERING; ENTEROCOCCAL INFECTION; FEMALE; HEALTH CARE MANAGEMENT; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT CARE; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SCHOOL CHILD; SURGICAL DRAINAGE; TEACHING HOSPITAL; URINARY CATHETER; VANCOMYCIN RESISTANT ENTEROCOCCUS; WORKFLOW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CHILD; CROSS INFECTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN RESISTANCE; YOUNG ADULT;

ENTEROCOCCUS;

EID: 84860368744     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822012000200009     Document Type: Article

References (23)

1. Tacconelli E, Cataldo MA. Vancomycin-resistant enterococci (VRE): transmission and control. Int J Antimicrobial Agents 2008; 31:99-106.
2. Sttobberingh E, Van Den Boggard A, London N, Driessen C, Top J, Willems R. Enterococci with glycopeptides resistance in turkeys, turkey farmes, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother 1999; 43:2215-2221.
3. Gambarotto K, Ploy MC, Turlure P, Grelaud C, Martin C, Denis F, et al. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and non hospitalized controls in a cattle-rearing area of France. J Clin Microbiol 2000; 38:620-624.
4. Olivier CN, Blake RK, Steed LL, Salgado CD. Risk of Vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 2008; 29:404-409.
5. Hsueh PR, Teng LJ, Pan HJ, Chen YC, Wang LH, Chang SC, et al. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol 1999; 20:828-833.
6. Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, Gold HS, et al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". Clin Infect Dis 2001; 33:1654-1660.
7. Ramsey AM, Zilberberg MD. Secular trends of hospitalization with vancomycinresistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 2009; 30:184-186.
8. Dalla Costa LM, Souza DC, Martins LT, Zanella RC, Brandilone MC, Bokermann S, et al. Vancomycin-resistant Enterococcus faecium: First case in Brazil. Braz J Infect Dis 1998; 2:160-163.
9. Tresoldi AT, Cardoso LG, Castilho GV, Dantas SR, Pereira RM, Trabasso P, et al. Low prevalence of Vancomycin resistant enterococci colonization in intensive care patients in a Brazilian teaching hospital. Braz J Infect Dis 2006;10:239-241.
10. Moretti ML, Cardoso LG, Trabasso P, Levy CE, Von Novakosky A, Bachur LF, et al. Controlling a vancomycin-resistant enterococci outbreak in a Brazilian teaching hospital. Eur J Clin Microbiol Infect Dis 2010; 30: 369-374.
11. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Inf 2007; 65: 50-54.
12. Harris AD. How important is the environment in the emergence of nosocomial antimicrobial-resistant bacteria? Clin Inf Dis 2008; 46: 686-688.
13. Dress M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008; 46: 678-685.
14. Warren DK, Nitin A, Hill C, Fraser VJ, Kollef MH. Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Inf Control Hosp Epidemiol 2004; 25:99-104,
15. Slaughter S, Hayden MK, Nathan C, Hu TC, Rice T, Van Voorhis J, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996; 125:448-456.
16. Armeanu E, Bonten M. Control of vancomycin-resistant enterococci: one size fits all? Clin Inf Dis 2005; 41:210-216
17. Calfee DP, Gianetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Inf Dis 2003; 37:326-332.
18. Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Hammond JM, et al. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med 2002; 28:692-697.
19. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. New Engl J Med 2000; 343:1925-1932.
20. Bradley SJ, Wilson AL, Allen MC, Sher HA, Goldstone AH, Scott GM. The control of hiperendemic glycopeptides-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antim Chemotherapy 1999; 43:261-266.
21. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant enterococci. Emerging Inf Dis 2002; 8:802-807.
22. Lautenbach E, La Rosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporin. Clin Infect Dis 2003: 36:440-446.
23. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Inf Control 2006; 34:534-546.